Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease

Abstract

The Fas-ligand SNP and <i>TNF</i> gene -308 SNP are associated with anti-TNF treatment response in CD and may help select patients likely to benefit from therapy.